financetom
Business
financetom
/
Business
/
Zai Lab Q3 Loss Narrows, Revenue Rises; 2025 Revenue Outlook Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zai Lab Q3 Loss Narrows, Revenue Rises; 2025 Revenue Outlook Revised
Nov 6, 2025 4:50 AM

07:42 AM EST, 11/06/2025 (MT Newswires) -- Zai Lab ( ZLAB ) reported a Q3 loss Thursday of $0.33 per American depositary share, narrower than a loss of $0.42 a year earlier.

Analysts polled by FactSet expected a loss of $0.29.

Total revenue for the quarter ended Sept. 30 was $116.1 million, compared with $102.3 million a year earlier.

Analysts surveyed by FactSet expected $141.7 million.

The company said it now expects full year 2025 total revenue of at least $460 million, compared with $560 million to $590 million guidance in August.

Shares of the company were down 6.7% in recent premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sealed Air Corp to go private in $10.3 billion deal with CD&R
Sealed Air Corp to go private in $10.3 billion deal with CD&R
Nov 17, 2025
Nov 17 (Reuters) - U.S. packaging company Sealed Air Corp ( SEE ) said on Monday it will go private after being bought by private investment firm CD&R for $10.3 billion, including debt. Under the agreement, Sealed Air ( SEE ) shareholders will receive $42.15 in cash per share, a nearly 13% premium to its closing price on November 11....
Safety products maker Brady's Q1 sales beat estimates 
Safety products maker Brady's Q1 sales beat estimates 
Nov 17, 2025
Overview * Brady fiscal Q1 sales rise 7.5%, beating analyst expectations * Adjusted EPS for fiscal Q1 beats analyst expectations, rising 8% yr/yr * Company raises low end of full-year adjusted EPS guidance Outlook * Brady raises low end of fiscal 2026 Adjusted Diluted EPS guidance to $4.90-$5.15 * Brady updates fiscal 2026 GAAP EPS guidance to $4.57-$4.82 due to...
Avadel Pharmaceuticals Determines Lundbeck Acquisition Offer Superior to Alkermes'
Avadel Pharmaceuticals Determines Lundbeck Acquisition Offer Superior to Alkermes'
Nov 17, 2025
07:13 AM EST, 11/17/2025 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) said Monday that the unsolicited acquisition proposal of up to about $2.4 billion or $23 per share it received from H. Lundbeck is superior to its existing agreement with Alkermes (ALKS). The offer is 29% above Avadel's closing price as of Oct. 21, the company said. H. Lundbeck's...
Market Chatter: Sinclair Builds 8% Stake in E.W. Scripps
Market Chatter: Sinclair Builds 8% Stake in E.W. Scripps
Nov 17, 2025
07:13 AM EST, 11/17/2025 (MT Newswires) -- Sinclair (SBGI) has accumulated an almost 8% stake in E.W. Scripps (SSP), the Wall Street Journal reported Monday, citing a regulatory filing. Sinclair is vying to acquire the local TV broadcaster, and the position is seen as a move to push Scripps into a deal after months of constructive talks, according to the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved